CRONOS GROUP INC (CRON.CA) Stock Price & Overview
TSX:CRON • CA22717L1013
Current stock price
The current stock price of CRON.CA is 3.75 CAD. Today CRON.CA is up by 5.63%. In the past month the price increased by 5.63%. In the past year, price increased by 57.56%.
CRON.CA Key Statistics
- Market Cap
- 1.42B
- P/E
- N/A
- Fwd P/E
- 41.04
- EPS (TTM)
- -0.01
- Dividend Yield
- N/A
CRON.CA Stock Performance
CRON.CA Stock Chart
CRON.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CRON.CA. When comparing the yearly performance of all stocks, CRON.CA is one of the better performing stocks in the market, outperforming 74.19% of all stocks.
CRON.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CRON.CA. No worries on liquidiy or solvency for CRON.CA as it has an excellent financial health rating, but there are worries on the profitability.
CRON.CA Earnings
On February 26, 2026 CRON.CA reported an EPS of 0 and a revenue of 44.53M. The company missed EPS expectations (-139.22% surprise) and beat revenue expectations (12.75% surprise).
CRON.CA Forecast & Estimates
9 analysts have analysed CRON.CA and the average price target is 4.67 CAD. This implies a price increase of 24.67% is expected in the next year compared to the current price of 3.75.
For the next year, analysts expect an EPS growth of 1757.5% and a revenue growth 31.91% for CRON.CA
CRON.CA Groups
Sector & Classification
CRON.CA Financial Highlights
Over the last trailing twelve months CRON.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -104% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.79% | ||
| ROE | -0.86% | ||
| Debt/Equity | 0 |
CRON.CA Ownership
CRON.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.25 | 2.931B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.117B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 5.16 | 895.726M | ||
| GUD | KNIGHT THERAPEUTICS INC | 45.08 | 758.752M | ||
| WEED | CANOPY GROWTH CORP | N/A | 733.967M | ||
| DHT-U | DRI HEALTHCARE TRUST | 3.71 | 643.734M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 18.56 | 486.64M | ||
| TSND | TERRASCEND CORP | N/A | 360.859M | ||
| HITI | HIGH TIDE INC | 15.84 | 295.344M | ||
| ACB | AURORA CANNABIS INC | 63.12 | 289.221M | ||
| OGI | ORGANIGRAM GLOBAL INC | 30.95 | 287.677M | ||
| CRDL | CARDIOL THERAPEUTICS INC-A | N/A | 218.049M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About CRON.CA
Company Profile
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The firm distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
Company Info
IPO: 2014-05-07
CRONOS GROUP INC
4491 Concession Rd 12
TORONTO ONTARIO M5V2G9 CA
CEO: Kurt T. Schmidt
Employees: 626
Phone: 14165040004
CRONOS GROUP INC / CRON.CA FAQ
What does CRON do?
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The firm distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
What is the stock price of CRONOS GROUP INC today?
The current stock price of CRON.CA is 3.75 CAD. The price increased by 5.63% in the last trading session.
What is the dividend status of CRONOS GROUP INC?
CRON.CA does not pay a dividend.
How is the ChartMill rating for CRONOS GROUP INC?
CRON.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the PE ratio for CRON stock?
CRONOS GROUP INC (CRON.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
What is the expected growth for CRON stock?
The Revenue of CRONOS GROUP INC (CRON.CA) is expected to grow by 31.91% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.